Journal of Vaccines & Vaccination

Purwono PB, Amin M, Bramanthi R, Resi EM, Wahyuni RM, et al. (2016) Hepatitis B Virus Infection in Indonesia 15 Years after Adoption of a Universal Infant Vaccination Program: Possible Impacts of Low Birth Dose Coverage and a Vaccine-Escape Mutant. The American Journal of Tropical Medicine and Hygiene 95: 674-679.

Yano Y, Utsumi T, Lusida MI, Hayashi Y (2015) Hepatitis B virus infection in Indonesia. World Journal of Gastroenterology: WJG 21: 10714.

Patel AC, Upmanyu V, Ramasamy S, Gupta PK, Singh R, et al. (2015) Molecular and immunogenic characterization of BHK-21 cell line adapted CVS-11 strain of rabies virus and future prospect in vaccination strategy. VirusDisease 26: 288-296.

Aga AM, Hurisa B, Urga K (2016) Current Situation of Rabies Prevention and Control in Developing Countries: Ethiopia Perspective. Journal of Ancient Diseases & Preventive Remedies pp:1-6.

Aga AM, Hurisa B, Urga K. Journal of Ancient Diseases & Preventive Remedies.

Grigoryan GV, Metlin AY (2016) Global Financial Crisis as a Challenge for Prevention of Human Rabies in the Former Soviet Republics. Austin Virol and Retrovirology 3: 1016.

Francia K. Inmovilización de β-galactosidasa y α-manosidasa: aplicación al estudio del potencial inmunomodulador de residuos glicosídicos presentes en Fasciola hepatica.

Noya V, Brossard N, Berasaín P, Rodríguez E, Chiale C, et al. (2016) A mucin-like peptide from Fasciola hepatica induces parasite-specific Th1-type cell immunity. Parasitology research 115: 1053-1063.

Garcia-Campos A, Ravidà A, Nguyen DL, Cwiklinski K, Dalton JP, et al. (2016) Tegument glycoproteins and cathepsins of Newly Excysted Juvenile Fasciola hepatica carry mannosidic and paucimannosidic N-glycans. PLoS Negl Trop Dis 10: e0004688.

Masika CW, Atieli H, Were T (2016) Knowledge, Perceptions, and Practice of Nurses on Surveillance of Adverse Events following Childhood Immunization in Nairobi, Kenya. BioMed Research International.

Ogunyemi RA, Odusanya OO (2016) A survey of knowledge and reporting practices of primary healthcare workers on adverse experiences following immunisation in Alimosho local Government area, Lagos. Nigerian Postgraduate Medical Journal 23: 79.

Bröker M, Berti F, Costantino P (2016) Factors contributing to the immunogenicity of meningococcal conjugate vaccines. Human vaccines & immunotherapeutics 12: 1808-1824.

Gasparini R, Tregnaghi M, Keshavan P, Ypma E, Han L, et al. (2016) Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine and commonly administered vaccines after coadministration. The Pediatric infectious disease journal 35: 81-93.

Fenstermaker RA, Ciesielski MJ, Qiu J, Yang N, Frank CL, et al. (2016) Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma. Cancer Immunology, Immunotherapy 65: 1339-1352.

Sah NK, Seniya C (2015) Survivin splice variants and their diagnostic significance. Tumor Biology 36: 6623-6631.

Vaishnavi C, Singh M, Thakur JS, Thapa BR (2015) Low prevalence of campylobacteriosis in the Northern region of India. Advances in Microbiology 5: 155.

Akladios C, Aprahamian M (2016) Virotherapy of digestive tumors with rodent parvovirus: overview and perspectives. Expert opinion on biological therapy 16: 645-653.

J Padhy, KA Lakshmi (2016) Approach Antimicrobial, Antioxidant and Anti-Inflammatory Activity of Hydroxychavicol on Cancer Cells. Research and Reviews: Journal of Pharmacognosy and Phytochemistry pp: 1-7

Geletneky K, Nüesch JP, Angelova A, Kiprianova I, Rommelaere J (2015) Double-faceted mechanism of parvoviral oncosuppression. Current opinion in virology 13: 17-24.

Marchini A, Bonifati S, Scott EM, Angelova AL, Rommelaere J (2015) Oncolytic parvoviruses: from basic virology to clinical applications. Virology journal 12: 6.